Patients' experiences of long-acting injectable antipsychotics: a qualitative study

被引:5
作者
Chiu, Lin-Ling [1 ]
Liu, Chun-Hao [2 ,3 ]
Chu, Chun-Lin [4 ]
Lin, Huang-Li [2 ]
Lii, Shu-Chung [5 ]
机构
[1] Chang Gung Univ, Coll Med, Sch Med, Taoyuan, Taiwan
[2] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp Linkou, Dept Child Psychiat, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp Taoyuan, Dept Psychiat, Taoyuan, Taiwan
[5] Chang Gung Univ, Coll Med, Humanist & Social Med Div, 259 Wen Hua 1st Rd, Taoyuan 333, Taiwan
关键词
antipsychotics; experience; long-acting injectable; LAI; qualitative research; SCHIZOPHRENIA; INJECTIONS; PROGRAM;
D O I
10.2147/NDT.S206154
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: In this study, we applied a qualitative approach to explore patients' subjective experiences of long-acting injectable antipsychotics (LAIs). Methods: Patients undergoing psychiatric treatment from the chronic ward or outpatient department of a medical center in northern Taiwan who had experience with LAI treatment were enrolled. Information was obtained through semi-structured in-depth interviews. The interviews were audio-recorded and then translated verbatim, and the data were collected and analyzed concurrently to develop major themes and categories. Result: In total, 14 participants (8 female) were interviewed. In a bio-psycho-social model, the participants used LAIs as a method to become "normal," in order to achieve a balance between the "effects" and "side effects" that may influence their daily lives. Their past experiences constructed their concepts about and expectations regarding LAIs, and their relationships with their family members and co-workers also modeled their experiences. Conclusion: In our study, we sought to understand the experience of LAI in the daily life context of the patients. We attempted to use a bio-psycho-social model to evaluate the subjective experience of the patients; an improved understanding can help mental health specialists gain a closer insight into patient experience.
引用
收藏
页码:1797 / 1804
页数:8
相关论文
共 50 条
  • [41] Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention
    Agid, Ofer
    Foussias, George
    Remington, Gary
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (14) : 2301 - 2317
  • [42] Handwriting Kinematics in Schizophrenia Patients Treated With Long-Acting Injectable Atypical Antipsychotics: Results From the Alpine Study
    Caligiuri, Michael
    Weiden, Peter
    Claxton, Amy
    Yagoda, Sergey
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (SUPPL 1) : 130 - 131
  • [43] Long-acting injectable antipsychotics for prevention and management of violent behaviour in psychotic patients
    Mohr, Pavel
    Knytl, Pavel
    Vorackova, Veronika
    Bravermanova, Anna
    Melicher, Tomas
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (09)
  • [44] Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
    Sugawara, Norio
    Kudo, Shuhei
    Ishioka, Masamichi
    Sato, Yasushi
    Kubo, Kazutoshi
    Yasui-Furukori, Norio
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 205 - 211
  • [45] Pharmacist Administration of Long-Acting Injectable Antipsychotics to Community-Dwelling Patients: A Scoping Review
    Murphy, Andrea L.
    Suh, Sowon
    Gillis, Louise
    Morrison, Jason
    Gardner, David M.
    PHARMACY, 2023, 11 (02)
  • [46] Long-acting injectable antipsychotics in early psychosis: a literature review
    Emsley, Robin
    Chiliza, Bonginkosi
    Asmal, Laila
    Mashile, Mpogisheng
    Fusar-Poli, Paolo
    EARLY INTERVENTION IN PSYCHIATRY, 2013, 7 (03) : 247 - 254
  • [47] ATTITUDES OF CROATIAN PSYCHIATRISTS TOWARDS LONG-ACTING INJECTABLE ANTIPSYCHOTICS
    Ciglar, Mirta
    Bjedov, Sarah
    Malekovic, Hrvoje
    PSYCHIATRIA DANUBINA, 2016, 28 (03) : 273 - 277
  • [48] Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database
    Voss, Erica A.
    Ryan, Patrick B.
    Stang, Paul E.
    Hough, David
    Alphs, Larry
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (03) : 151 - 157
  • [49] Converting Oral to Long-Acting Injectable Antipsychotics: A Guide for the Perplexed
    Meyer, Jonathan M.
    CNS SPECTRUMS, 2017, 22 : 14 - 28
  • [50] LONG-ACTING INJECTABLE ANTIPSYCHOTICS: FROM PHARMACOKINETICS TO THE BENEFITS FOR THE PATIENT
    Fraguas, D.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 5 - 6